(a) No person shall manufacture, obtain, possess, administer or dispense a legend drug, controlled substance or controlled substance analogue for the purpose of scientific research, chemical analysis, instruction or training of detection animals without having first secured a license to do so from the director.
(b) An application for the license shall be submitted on the prescribed form, and shall be accompanied by:(1) A nonrefundable fee of thirty dollars ($30.00), or in an amount set by the board;(2) Copies of all papers and materials filed with any state or federal governmental agency in connection with the applicant's proposed project; and(3) A detailed protocol, in triplicate, setting forth:(A) The nature of the proposed project;(B) The qualifications of the applicant to engage in the project;(C) The proposed quantity of each drug involved;(D) The measures proposed to provide for security and proper record-keeping of the drugs;(E) Specific provisions for the safe administration or dispensing of drugs to humans, if contemplated, and the proposed method for selecting the humans; and(F) Other information the commissioner may require.
(1) A nonrefundable fee of thirty dollars ($30.00), or in an amount set by the board;
(2) Copies of all papers and materials filed with any state or federal governmental agency in connection with the applicant's proposed project; and
(3) A detailed protocol, in triplicate, setting forth:(A) The nature of the proposed project;(B) The qualifications of the applicant to engage in the project;(C) The proposed quantity of each drug involved;(D) The measures proposed to provide for security and proper record-keeping of the drugs;(E) Specific provisions for the safe administration or dispensing of drugs to humans, if contemplated, and the proposed method for selecting the humans; and(F) Other information the commissioner may require.
(A) The nature of the proposed project;
(B) The qualifications of the applicant to engage in the project;
(C) The proposed quantity of each drug involved;
(D) The measures proposed to provide for security and proper record-keeping of the drugs;
(E) Specific provisions for the safe administration or dispensing of drugs to humans, if contemplated, and the proposed method for selecting the humans; and
(F) Other information the commissioner may require.